TRVI News and Press, Trevi Therapeutics Inc.

Trevi Therapeutics to Participate in Upcoming Investor and Healthcare Events PR Newswire Two abstracts accepted for oral presentation at the 13 th London International Cough Symposium NEW HAVEN, Conn. , July 2, 2024 /PRNewswire/ -- Trevi Therapeutic...

2024-05-11 13:56:10 ET Trevi Therapeutics, Inc. (TRVI) Q1 2024 Earnings Conference Call May 7, 2024 4:30 PM ET Company Participants Jennifer Good - President and Chief Executive Officer Lisa Delfini - Chief Financial Officer David Clark - Chief Medical Officer ...

Trevi Therapeutics to Participate in Upcoming Conferences PR Newswire NEW HAVEN, Conn. , May 9, 2024 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™...

Trevi Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates PR Newswire Reaffirms guidance for the Phase 2a RIVER trial in refractory chronic cough and Human Abuse Potential (HAP) Study with topline data for each expected in the second half of...

Trevi Therapeutics to Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 7, 2024 PR Newswire Conference call and webcast to be held at 4:30 p.m. ET NEW HAVEN, Conn. , May 1, 2024 /PRNewswire/ -- Trevi Therapeutics, Inc...

Trevi Therapeutics Announces Abstract Presentation at the American Thoracic Society 2024 International Conference PR Newswire Professor Jacky Smith will present on the reduction of cough bouts with nalbuphine ER observed in patients with IPF in the CANAL trial NE...

Trevi Therapeutics to Participate in Upcoming April Events PR Newswire NEW HAVEN, Conn. , April 4, 2024 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio!...

2024-04-02 16:43:27 ET Gainers: Sight Sciences ( SGHT ) +19% . Zapata Computing Holdings  ( ZPTA ) +9% . Cal-Maine Foods ( CALM ) +6% . Vanda Pharmaceuticals  ( VNDA ) +5% . iHeartMedia ( IHRT ) +5% . Losers: Ac...

Trevi Therapeutics Adds Clinical Development Expertise in Chronic Cough to Leadership Team PR Newswire Margaret Garin , MD, MSCR, joins team to advance the development of Haduvio in chronic cough indications NEW HAVEN, Conn. , April 2, 2024 /PRNewswir...

2024-03-20 18:21:10 ET Trevi Therapeutics, Inc. (TRVI) Q4 2023 Earnings Conference Call March 20, 2024 04:30 PM ET Company Participants Jennifer Good - President & CEO Lisa Delfini - CFO David Clark - Chief Medical Officer Conference Call Participants ...